PARP inhibitors – a new direction in the treatment of breast and ovarian cancer

Karol Gawalski(Medical University of Warsaw), Włodzimierz Sawicki(Medical University of Warsaw), Magdalena Bizoń, Krzysztof Cendrowski(West Pomeranian University of Technology in Szczecin), Bohdan Dźwigała(Medical University of Warsaw)
Ginekologia Onkologiczna/Current Gynecologic Oncology
May 31, 2022
Cited by 2


Related Papers